N1VO34:BVMF
Novo Nordisk Bdr
24,05 BRL
arrow_upward
+0,54%(+0,13) 1D
14-окт., 17:06:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for N1VO34...
Open
23,98 BRL
High
24,14 BRL
Low
23,80 BRL
Mkt. cap
130,07 млд
Avg. vol.
34,84 миң
Volume
3,65 миң
52-wk high
42,43 BRL
52-wk low
22,90 BRL
Shares outstanding
3,39 млд
No. of employees
67 миң
Open
23,98 BRL
High
24,14 BRL
Low
23,80 BRL
Mkt. cap
130,07 млд
Avg. vol.
34,84 миң
Volume
3,65 миң
52-wk high
42,43 BRL
52-wk low
22,90 BRL
Shares outstanding
3,39 млд
No. of employees
67 миң
News stories
From web sources and news partners
Yahoo Finance
·
4 саат мурун
Is Novo Nordisk (NYSE:NVO) A Long Term Value Opportunity Now?
The Motley Fool
·
22 саат мурун
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks
·
1 күн мурун
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
Yahoo Finance
·
2 күн мурун
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk Bdr
CEOMaziar Mike Doustdar
Employees66,7 миң
Founded1923
HeadquartersBagsværd, Capital Region of Denmark, Дания
SectorPharmaceutical industry
Websitenovonordisk.com